Southpoint Capital Advisors’s VolitionRx Ltd VNRX Stock Holding History

Southpoint Capital Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,274	Closed	-$698K	–	38
2017 Q3	$698K	Sell	13,274 -26,326	-66%	-$1.55M	0.03%	36
2017 Q2	$2.8M	Sell	39,600 -400	-1%	-$28.9K	0.11%	40
2017 Q1	$3.22M	Hold	40,000	–	–	0.14%	31
2016 Q4	$3.66M	Hold	40,000	–	–	0.17%	30
2016 Q3	$4.24M	Hold	40,000	–	–	0.19%	28
2016 Q2	$2.52M	Hold	40,000	–	–	0.13%	25
2016 Q1	$2.84M	Hold	40,000	–	–	0.14%	27
2015 Q4	$3.6M	Hold	40,000	–	–	0.17%	29
2015 Q3	$3.58M	Hold	40,000	–	–	0.16%	31
2015 Q2	$3.16M	Hold	40,000	–	–	0.13%	32
2015 Q1	$3.29M	Buy	+40,000	New	+$3.31M	0.14%	32

Other funds holding VNRX

LIM

Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Southpoint Capital Advisors's VNRX Position: Q4 2017 in Review

Southpoint Capital Advisors sold out of VolitionRx Ltd (VNRX) in Q4 2017, closing a stake of 13,274 shares — an estimated $698K sold.

Southpoint Capital Advisors first reported a position in VNRX in Q1 2015 and held it in 11 quarters. The position peaked at $4.24M in Q3 2016. 18 funds tracked by Wall St. Rank hold VNRX as of Q4 2017.

Southpoint Capital Advisors reported no remaining VolitionRx Ltd position as of Q4 2017 after selling out during the quarter.
Southpoint Capital Advisors sold 13,274 VolitionRx Ltd shares in Q4 2017, an estimated $698K.
Southpoint Capital Advisors first reported a position in VolitionRx Ltd in Q1 2015 and held it in 11 quarters.
Southpoint Capital Advisors's VolitionRx Ltd position peaked at $4.24M in Q3 2016.
18 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2017.

Based on Southpoint Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.